SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-16-000102
Filing Date
2016-11-04
Accepted
2016-11-04 08:01:58
Documents
86
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20160930x10q.htm 10-Q 1752278
2 EX-31.1 petx-20160930xex31_1.htm EX-31.1 19911
3 EX-31.2 petx-20160930xex31_2.htm EX-31.2 20243
4 EX-32.1 petx-20160930xex32_1.htm EX-32.1 6849
5 EX-32.2 petx-20160930xex32_2.htm EX-32.2 7497
6 GRAPHIC petx-20160930x10qg001.jpg GRAPHIC 50169
7 GRAPHIC petx-20160930x10qg002.jpg GRAPHIC 48408
8 GRAPHIC petx-20160930x10qg003.jpg GRAPHIC 26548
  Complete submission text file 0001509190-16-000102.txt   8112789

Data Files

Seq Description Document Type Size
9 EX-101.INS petx-20160930.xml EX-101.INS 1961305
10 EX-101.SCH petx-20160930.xsd EX-101.SCH 53367
11 EX-101.CAL petx-20160930_cal.xml EX-101.CAL 59061
12 EX-101.DEF petx-20160930_def.xml EX-101.DEF 199647
13 EX-101.LAB petx-20160930_lab.xml EX-101.LAB 385870
14 EX-101.PRE petx-20160930_pre.xml EX-101.PRE 377106
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 161973669
SIC: 2834 Pharmaceutical Preparations